Press release
April 28, 2022
Immunicom Presents New Data at AACR 2022 of LW-02 Cartridge Immunopheresis® Therapy from Ongoing mTNBC Clinical Trial in Chemo-Refractory Patients
April 12, 2022
Immunicom Announces Addition of Key Industry Leaders to Board of Directors
March 3, 2022
Immunicom Announces Dr. Julie Tubbs and Marilyn Panahi to Join Senior Leadership Team
March 1, 2022
Immunicom Appoints Jennifer Haldeman as Vice President of Commercial Operations
February 17, 2022